Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis
- 741 Downloads
The aim of this study was to document the available evidence on the use of regenerative techniques for the treatment of femoral head osteonecrosis (or avascular necrosis of femoral head, AVN) and to understand their benefit compared to core decompression (CD) alone in avoiding failure and the need for total hip replacement (THR).
The search was conducted on three medical electronic databases according to PRISMA guidelines. The studies reporting number and timing of failures were included in a meta-analysis calculating cumulative survivorship with a Kaplan-Mayer curve. Moreover, the results on failures in treatment groups reported in RCT were compared with those documented in control groups, in order to understand the benefit of biological therapies compared to CD for the treatment of AVN.
Forty-eight studies were included in this systematic review, reporting results of different types of regenerative techniques: mesenchymal stem cell implantation in the osteonecrotic area, intra-arterial infiltration with mesenchymal stem cells, implantation of bioactive molecules, or platelet-rich plasma. Overall, reported results were good, with a cumulative survivorship of 80% after ten year follow-up, and better results when regenerative treatments were combined to CD compared to CD alone (89.9% vs 70.6%, p < 0.0001).
Regenerative therapies offer good clinical results for the treatment of AVN. The combination of CD with regenerative techniques provides a significant improvement in terms of survivorship over time compared with CD alone. Further studies are needed to identify the best procedure and the most suitable patients to benefit from regenerative treatments for AVN.
KeywordsHip Avascular necrosis of femoral head Osteonecrosis Regenerative therapies Biological therapies Core decompression
The authors thank Elettra Pignotti for the assistance in the statistical analysis and Lucia Mancini for English editing.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res:295–310Google Scholar
- 10.Tian DH, De Silva RP, Wang T, Yan TD (2014) Open surgical repair for chronic type B aortic dissection: a systematic review. Ann Cardiothorac Surg 3:340–350. https://doi.org/10.3978/j.issn.2225-319X.2014.07.10 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Pilge H, Bittersohl B, Schneppendahl J et al (2016) Bone marrow aspirate concentrate in combination with intravenous iloprost increases bone healing in patients with avascular necrosis of the femoral head: a matched pair analysis. Orthop Rev (Pavia) 8:6902. https://doi.org/10.4081/or.2016.6902 CrossRefGoogle Scholar
- 13.Gianakos AL, Moya-Angeler J, Duggal S et al (2016) The efficacy of bisphosphonates with core decompression and mesenchymal stem cells compared with bisphosphonates alone in the treatment of osteonecrosis of the hip: a retrospective study. HSS J 12:137–144. https://doi.org/10.1007/s11420-016-9487-7 CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Mishima H, Sugaya H, Yoshioka T et al (2016) The safety and efficacy of combined autologous concentrated bone marrow grafting and low-intensity pulsed ultrasound in the treatment of osteonecrosis of the femoral head. Eur J Orthop Surg Traumatol 26:293–298. https://doi.org/10.1007/s00590-016-1752-4 CrossRefPubMedGoogle Scholar
- 17.Cruz-Pardos A, Garcia-Rey E, Ortega-Chamarro JA, Duran-Manrique D, Gomez-Barrena E (2016) Mid-term comparative outcomes of autologous bone-marrow concentration to treat osteonecrosis of the femoral head in standard practice. Hip Int 26:432–437. https://doi.org/10.5301/hipint.5000366 CrossRefPubMedGoogle Scholar
- 19.Tabatabaee RM, Saberi S, Parvizi J, Mortazavi SM, Farzan M (2015) Combining concentrated autologous bone marrow stem cells injection with Core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplast 30:11–15. https://doi.org/10.1016/j.arth.2015.06.022 CrossRefGoogle Scholar
- 22.Novais EN, Sankar WN, Wells L, Carry PM, Kim YJ (2015) Preliminary results of multiple epiphyseal drilling and autologous bone marrow implantation for osteonecrosis of the femoral head secondary to sickle cell disease in children. J Pediatr Orthop 35:810–815. https://doi.org/10.1097/BPO.0000000000000381 CrossRefPubMedGoogle Scholar
- 23.Ma Y, Wang T, Liao J et al (2014) Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther 5:115. https://doi.org/10.1186/scrt505 CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Liu Y, Liu S, Su X (2013) Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head. Arch Orthop Trauma Surg 133:125–133. https://doi.org/10.1007/s00402-012-1623-3 CrossRefPubMedGoogle Scholar
- 29.Kang JS, Moon KH, Kim BS et al (2013) Clinical results of auto-iliac cancellous bone grafts combined with implantation of autologous bone marrow cells for osteonecrosis of the femoral head: a minimum 5-year follow-up. Yonsei Med J 54:510–515. https://doi.org/10.3349/ymj.2013.54.2.510 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N (2012) Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis. a randomized control study J Arthroplasty 27:679–686. https://doi.org/10.1016/j.arth.2011.08.008 CrossRefPubMedGoogle Scholar
- 32.Yoshioka T, Mishima H, Akaogi H, Sakai S, Li M, Ochiai N (2011) Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 35:823–829. https://doi.org/10.1007/s00264-010-1048-y CrossRefPubMedGoogle Scholar
- 33.Gangji V, De Maertelaer V, Hauzeur JP (2011) Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone 49:1005–1009. https://doi.org/10.1016/j.bone.2011.07.032 CrossRefPubMedGoogle Scholar
- 34.Yamasaki T, Yasunaga Y, Ishikawa M, Hamaki T, Ochi M (2010) Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: a preliminary study. J Bone Joint Surg Br 92:337–341. https://doi.org/10.1302/0301-620X.92B3.22483 CrossRefPubMedGoogle Scholar
- 35.Wang BL, Sun W, Shi ZC et al (2010) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 130:859–865. https://doi.org/10.1007/s00402-009-0939-0 CrossRefPubMedGoogle Scholar
- 41.Aoyama T, Fujita Y, Madoba K et al (2015) Rehabilitation program after mesenchymal stromal cell transplantation augmented by vascularized bone grafts for idiopathic osteonecrosis of the femoral head: a preliminary study. Arch Phys Med Rehabil 96:532–539. https://doi.org/10.1016/j.apmr.2014.09.040 CrossRefPubMedGoogle Scholar
- 42.Zhao D, Liu B, Wang B et al (2015) Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head. Biomed Res Int 2015:240506. https://doi.org/10.1155/2015/240506 CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Aoyama T, Goto K, Kakinoki R et al (2014) An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev 20:233–242. https://doi.org/10.1089/ten.TEB.2014.0090 CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Kawate K, Yajima H, Ohgushi H et al (2006) Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30:960–962. https://doi.org/10.1111/j.1525-1594.2006.00333.x CrossRefPubMedGoogle Scholar
- 46.Chotivichit A, Korwutthikulrangsri E, Pornrattanamaneewong C, Achawakulthep C (2014) Core decompression with bone marrow injection for the treatment of femoral head osteonecrosis. J Med Assoc Thail 97(Suppl 9):S139–S143Google Scholar
- 50.Mao Q, Wang W, Xu T et al (2015) Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial. J Bone Miner Res 30:647–656. https://doi.org/10.1002/jbmr.2390 CrossRefPubMedPubMedCentralGoogle Scholar
- 52.Mao Q, Jin H, Liao F, Xiao L, Chen D, Tong P (2013) The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study. Bone 57:509–516. https://doi.org/10.1016/j.bone.2013.08.022 CrossRefPubMedPubMedCentralGoogle Scholar
- 53.Cai J, Wu Z, Huang L et al (2014) Cotransplantation of bone marrow mononuclear cells and umbilical cord mesenchymal stem cells in avascular necrosis of the femoral head. Transplant Proc 46:151–155. https://doi.org/10.1016/j.transproceed.2013.06.021 CrossRefPubMedGoogle Scholar
- 57.Kuroda Y, Asada R, So K et al (2016) A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. Int Orthop 40:1747–1754. https://doi.org/10.1007/s00264-015-3083-1 CrossRefPubMedGoogle Scholar
- 70.Osmani F, Thakkar S, Vigdorchik J (2017) The utility of conservative treatment modalities in the Management of Osteonecrosis. Bull Hosp Jt Dis (2013) 75:186–192Google Scholar